PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
|
24989451 |
2014 |
Spinal Muscular Atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.
|
29656927 |
2018 |
Neurodegenerative Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
In contrast, mutations in the structural exosome genes EXOSC3 and EXOSC8 cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are related autosomal recessive, neurodegenerative diseases.
|
31768969 |
2020 |
Neurodegenerative Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in the RNA exosome genes <i>EXOSC3</i> and <i>EXOSC8</i> cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are similar autosomal-recessive, neurodegenerative diseases.
|
29093021 |
2018 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B
|
0.020 |
Biomarker
|
disease |
BEFREE |
In contrast, mutations in the structural exosome genes EXOSC3 and EXOSC8 cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are related autosomal recessive, neurodegenerative diseases.
|
31768969 |
2020 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the RNA exosome genes <i>EXOSC3</i> and <i>EXOSC8</i> cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are similar autosomal-recessive, neurodegenerative diseases.
|
29093021 |
2018 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, functional experiments confirmed the oncogenic roles of EXOSC8 in colorectal carcinoma.
|
31548613 |
2020 |
Muscle Spasticity
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.
|
29656927 |
2018 |
nervous system disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here we show that homozygous missense mutations in EXOSC8 cause progressive and lethal neurological disease in 22 infants from three independent pedigrees.
|
24989451 |
2014 |
Congenital pontocerebellar hypoplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in its subunits EXOSC8 and EXOSC3 cause pontocerebellar hypoplasia, spinal muscular atrophy (SMA) and central nervous system demyelination.
|
27193168 |
2016 |
Central nervous system demyelination
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in its subunits EXOSC8 and EXOSC3 cause pontocerebellar hypoplasia, spinal muscular atrophy (SMA) and central nervous system demyelination.
|
27193168 |
2016 |
Pontoneocerebellar hypoplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in its subunits EXOSC8 and EXOSC3 cause pontocerebellar hypoplasia, spinal muscular atrophy (SMA) and central nervous system demyelination.
|
27193168 |
2016 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spinal Muscular Atrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spastic tetraparesis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory Failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
hearing impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar vermis hypoplasia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Visual Impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|